ACTRN12613000762752
Active, Not Recruiting
N/A
All cause and cardiovascular mortality among Australian adult dialysis patients prescribed sevelamer hydrochloride and lanthanum carbonate compared with calcium-based phosphate binders.
A/Prof Grahame Elder0 sites15,000 target enrollmentJuly 9, 2013
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- A/Prof Grahame Elder
- Enrollment
- 15000
- Status
- Active, Not Recruiting
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Australian dialysis patients aged over 18 years of age and registered in ANZDATA registry will be included in the study.
Exclusion Criteria
- •New Zealand patients and patients aged less than 18 years of age in ANZDATA registry will be excluded
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Mortality and risk factors for cardiovascular and non-cardiovascular disease in Japanese with impaired glucose metabolismJPRN-UMIN000036648Hiroshima Atomic Bomb Casualty Council19,248
Active, Not Recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2012-003946-34-CZVIVUS, Inc.16,000
Active, Not Recruiting
Phase 1
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 14.1Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2012-003946-34-SKVIVUS, Inc.16,000
Active, Not Recruiting
N/A
A study to test whether VI-0521 or placebo (contains no active drug substance) reduce the chances of developing health problems related to the functioning of the heart and vascular system (blood vessels), such as heart attacks or strokes.Cardiovascular Disease in overweight and obese subjectsMedDRA version: 16.0Level: LLTClassification code 10007648Term: Cardiovascular disease, unspecifiedSystem Organ Class: 100000004849Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]EUCTR2012-003946-34-GBVIVUS, Inc.16,000
Completed
N/A
Risk factors for mortality and cardiovascular diseases in older adults in a primaray care setting – longitudinal analysis of the getABI-studyRisk factors for mortality and cardiovascular diseasesI70.20DRKS00011624Ruhr-Universität Bochum6,880